{"title":"PROGRESSION AND PERSPECTIVE, A 20-YEAR RETROSPECTIVE ON SYSTEMATIC LUPUS ERYTHEMATOSUS THERAPEUTICS: A NARRATIVE REVIEW","authors":"Nixat Patel, Tirth Hinsu, Shivangi Sharma, Meetkumar Pipaliy, Dhruvin Patel, Jahanvi Kasodariya, Jetal Joshi, Yugam Rajeshkumar Oza","doi":"10.36106/ijsr/2608816","DOIUrl":null,"url":null,"abstract":"This study aims to examine efcacy and safety of current regimen in comparison to novel therapeutic regimens with treat-to-target strategies and\nagents consisting of non-steroidal immunosuppressants, biologics, and nonpharmacologic treatment options. This study also highlights future\ntreatment options under investigation, aiming to identify potential avenues for improved patient care and disease control. Novel therapies have\nshown greater improvements in treatment of SLE which would cause decrease in use of steroids and more patient specic targeted therapies. This\nwill help in identifying any knowledge gaps and propose future research directions to address the same and contribute to the enhancement of patient\noutcomes and quality of life by providing insights into optimal approaches to SLE management.","PeriodicalId":14358,"journal":{"name":"International journal of scientific research","volume":"17 11","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of scientific research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36106/ijsr/2608816","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
This study aims to examine efcacy and safety of current regimen in comparison to novel therapeutic regimens with treat-to-target strategies and
agents consisting of non-steroidal immunosuppressants, biologics, and nonpharmacologic treatment options. This study also highlights future
treatment options under investigation, aiming to identify potential avenues for improved patient care and disease control. Novel therapies have
shown greater improvements in treatment of SLE which would cause decrease in use of steroids and more patient specic targeted therapies. This
will help in identifying any knowledge gaps and propose future research directions to address the same and contribute to the enhancement of patient
outcomes and quality of life by providing insights into optimal approaches to SLE management.